Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mizue Terai"'
Autor:
Clemens Krepler, Katrin Sproesser, Patricia Brafford, Marilda Beqiri, Bradley Garman, Min Xiao, Batool Shannan, Andrea Watters, Michela Perego, Gao Zhang, Adina Vultur, Xiangfan Yin, Qin Liu, Ioannis N. Anastopoulos, Bradley Wubbenhorst, Melissa A. Wilson, Wei Xu, Giorgos Karakousis, Michael Feldman, Xiaowei Xu, Ravi Amaravadi, Tara C. Gangadhar, David E. Elder, Lauren E. Haydu, Jennifer A. Wargo, Michael A. Davies, Yiling Lu, Gordon B. Mills, Dennie T. Frederick, Michal Barzily-Rokni, Keith T. Flaherty, Dave S. Hoon, Michael Guarino, Joseph J. Bennett, Randall W. Ryan, Nicholas J. Petrelli, Carol L. Shields, Mizue Terai, Takami Sato, Andrew E. Aplin, Alexander Roesch, David Darr, Steve Angus, Rakesh Kumar, Ensar Halilovic, Giordano Caponigro, Sebastien Jeay, Jens Wuerthner, Annette Walter, Matthias Ocker, Matthew B. Boxer, Lynn Schuchter, Katherine L. Nathanson, Meenhard Herlyn
Publikováno v:
Cell Reports, Vol 21, Iss 7, Pp 1953-1967 (2017)
Summary: Therapy of advanced melanoma is changing dramatically. Following mutational and biological subclassification of this heterogeneous cancer, several targeted and immune therapies were approved and increased survival significantly. To facilitat
Externí odkaz:
https://doaj.org/article/3165039b88f34a199db1a3519c05d121
Autor:
Michael J. Guarino, Min Xiao, Giorgos C. Karakousis, Michael A. Davies, Andrea Watters, Ensar Halilovic, Gao Zhang, Alexander Roesch, Lauren E. Haydu, Giordano Caponigro, Keith T. Flaherty, Clemens Krepler, Katrin Sproesser, Gordon B. Mills, Sébastien Jeay, Andrew E. Aplin, Lynn M. Schuchter, Nicholas J. Petrelli, Joseph J. Bennett, Adina Vultur, David E. Elder, Meenhard Herlyn, Ravi K. Amaravadi, Michael Feldman, Xiangfan Yin, Melissa Wilson, Tara C. Gangadhar, Rakesh Kumar, Michela Perego, Carol L. Shields, Katherine L. Nathanson, Marilda Beqiri, Jennifer A. Wargo, Matthias Ocker, Takami Sato, Qin Liu, Michal Barzily-Rokni, Batool Shannan, Ioannis N. Anastopoulos, Dennie T. Frederick, Bradley Garman, Xiaowei Xu, Dave S.B. Hoon, Mizue Terai, Randall W Ryan, Yiling Lu, Bradley Wubbenhorst, Patricia Brafford, Matthew B. Boxer, Annette O. Walter, Wei Xu, Jens Wuerthner, Steve Angus, David B. Darr
Publikováno v:
Cell Reports, Vol 21, Iss 7, Pp 1953-1967 (2017)
Summary: Therapy of advanced melanoma is changing dramatically. Following mutational and biological subclassification of this heterogeneous cancer, several targeted and immune therapies were approved and increased survival significantly. To facilitat